Ticker Details
AtriCure, Inc. AtriCure Inc is a medical device company. It develops, manufactures and sells cardiac surgical ablation systems designed to create precise lesions, scars in cardiac, heart, and tissue. It generates revenue by selling disposable surgical devices.
IPO Date:	August 5, 2005
Sector:	Healthcare
Industry:	Health Care Equipment and Supplies
Market Cap:	$2.49B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.48 | 2.23%
Avg Daily Range (30 D):	$0.92 | 2.37%
Avg Daily Range (90 D):	$0.76 | 2.39%

Institutional Daily Volume
Avg Daily Volume:	.19M
Avg Daily Volume (30 D):	.68M
Avg Daily Volume (90 D):	.7M

Trade Size
Avg Trade Size (Sh.):	69
Avg Trade Size (Sh.) (30 D):	50
Avg Trade Size (Sh.) (90 D):	53

Institutional Trades
Total Institutional Trades:	3,608
Avg Institutional Trade:	$1.86M
Avg Institutional Trade (30 D):	$2.83M
Avg Institutional Trade (90 D):	$2.83M
Avg Institutional Trade Volume:	.05M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.21M
Avg Closing Trade (30 D):	$4.36M
Avg Closing Trade (90 D):	$4.44M
Avg Closing Volume:	59.2K

News

Aug 7, 2026 @ 10:27 PM Two AtriCure Directors Trimmed Shares After a Stro... Source: Jonathan Ponciano

Nov 29, 2025 @ 9:24 PM Is AtriCure Stock a Buy or Sell After a Director D... Source: Robert Izquierdo

May 14, 2025 @ 6:00 PM Questex’s Fierce Healthcare Announces 2025 ... Source: Questex'S Fierce Healthcare

Jul 23, 2024 @ 6:08 PM AtriCure gains China's nod for heart surgery devic... Source: Natashya Angelica

May 2, 2024 @ 12:01 PM Cracking The Code: Understanding Analyst Reviews F... Source: Benzinga Insights

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$.21	$.18	$
Diluted EPS	$.21	$.18	$
Revenue	$569.62M	$153.6M	$141.25M
Gross Profit	$434.61M	$118.63M	$109.31M
Net Income / Loss	$10.55M	$8.96M	$.11M
Operating Income / Loss	$12.89M	$9.67M	$.53M
Cost of Revenue	$135.01M	$34.98M	$31.94M
Net Cash Flow	$49.99M	$21.62M	$-21.26M
PE Ratio